type II RAF inhibitors(oronoi/B2SBIO)

N/A

Report date: 2025/06/11 11:23:38
NME

Base Information

Drug Nametype II RAF inhibitors(oronoi/B2SBIO)
Drug Alias NameVRN-14AVRN-14B
ClassificationSmall molecules
Mechanisms of ActionSerine/threonine-protein kinase B-raf inhibitorsAnticancer protein kinase inhibitors
TargetsSerine/threonine-protein kinase B-raf
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVoronoi Inc
China Registration ClassN/A

Develop Information

Active CompaniesB2sbio Co LtdVoronoi Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A